Strawberry Fields REIT, Inc. (NYSE American: STRW) operates as a self-administered real estate investment trust focused on owning, acquiring, and leasing skilled nursing and other healthcare properties under triple-net leases. The third-quarter 2026 results provide a useful window into how the company is managing acquisition growth while cleaning up its balance sheet. Management retired several bond series denominated in Israeli shekels, which produced a sizable but non-recurring foreign-exchange loss. From what I see, the report tests whether the underlying rent-collection and cash-flow profile holds steady even as GAAP earnings turn negative for the period.
Rental revenues reached $40.0 million for the quarter ended September 30, 2026, a modest 0.7% increase from $39.7 million in the same period last year. The company continued to collect 100% of contractual rents. On a GAAP basis, STRW posted a net loss of $14.7 million versus net income of $8.8 million a year earlier. The primary driver was the $24.6 million foreign-currency transaction loss tied to the retirement of Bond Series A, C, and D. Net loss attributable to common stockholders came to $3.63 million, or $0.26 per share, compared with net income of $0.16 per share in the third quarter of 2025.
Funds From Operations, the standard REIT earnings metric, landed at -$3.6 million, or -$0.65 per share. After removing the one-time currency item and straight-line rent adjustments, Adjusted Funds From Operations climbed 3.6% to $18.8 million, or $0.34 per share, from $0.33 per share in the prior-year quarter. Over the first nine months, rental revenue rose 4% to $120.0 million and AFFO reached $55.9 million, or $1.00 per share. I also checked this using Tickeron’s AI Screener to see how STRW compares with peers on key cash-flow metrics.
The headline GAAP net loss prompted a cautious initial response, which is understandable given the sharp swing from profit to loss. Yet the more meaningful takeaway was the resilience of AFFO and the uninterrupted 100% rent collection. REIT investors tend to emphasize these cash-flow measures, so attention quickly turned to whether retiring the shekel-denominated debt would simplify the capital structure and limit future currency volatility. In my view, that development looks constructive once the one-time charge drops out of year-over-year comparisons.
Going forward, the focus shifts to how STRW redeploys its cleaner balance sheet into new acquisitions. Management has indicated a more measured pace this year while still targeting off-market, mid-sized deals. After the quarter, the company agreed to acquire a 99-bed skilled nursing facility in Angola, Indiana, for about $15 million, with closing expected by year-end.
Another potential catalyst is a tenant’s notice of intent to exercise a purchase option on 13 Arkansas properties for roughly $90 million. Those assets currently generate about $12 million in annual rent. If the deal closes before December 31 as expected, it would mark a sizable monetization event and could influence near-term revenue and cash-flow trends.
Cost trends warrant attention as well. General and administrative expenses increased due to fees related to a new line of credit and term loan, plus higher executive compensation. Interest expense eased slightly, aided by the bond payoff and modestly lower borrowing rates. The central question remains whether acquisition activity and rent growth can offset rising overhead while maintaining comfortable leverage and dividend coverage.
When analyzing healthcare REITs like STRW, I often turn to Tickeron’s AI Screener to quickly compare fundamentals, technical patterns, and sector momentum. It helps surface comparable names and highlights shifts that might otherwise take longer to identify manually. This kind of tool fits naturally into a broader review of cash-flow stability and acquisition pipelines.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
STRW saw its Momentum Indicator move below the 0 level on November 05, 2026. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 91 similar instances where the indicator turned negative. In 59 of the 91 cases, the stock moved further down in the following days. The odds of a decline are at 65%.
The Moving Average Convergence Divergence Histogram (MACD) for STRW turned negative on November 06, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 39 similar instances when the indicator turned negative. In 21 of the 39 cases the stock turned lower in the days that followed. This puts the odds of success at 54%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where STRW declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 63%.
The Aroon Indicator for STRW entered a downward trend on November 06, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where STRW's RSI Oscillator exited the oversold zone, 11 of 13 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 85%.
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 31 of 42 cases where STRW's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 74%.
Following a +4.64% 3-day Advance, the price is estimated to grow further. Considering data from situations where STRW advanced for three days, in 123 of 190 cases, the price rose further within the following month. The odds of a continued upward trend are 65%.
STRW may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Tickeron SMR rating for this company is 17 (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is 55 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 59 (best 1 - 100 worst), indicating fairly steady price growth. STRW’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 68 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: STRW's P/B Ratio (20.783) is very high in comparison to the industry average of (3.134). P/E Ratio (18.646) is within average values for comparable stocks, (30.791). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.649). Dividend Yield (0.056) settles around the average of (0.050) among similar stocks. STRW's P/S Ratio (1.132) is slightly lower than the industry average of (6.013).
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. STRW’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 57, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Industry PublishingBooksMagazines